| 臺大學術典藏 |
2021-02-02T05:45:29Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.;Chen C.-C.;Chang C.-Y.;Chen M.-J.;Fang Y.-J.;Lee J.-Y.;Chen C.-C.;Hsu S.-J.;Hsu Y.-C.;Tseng C.-H.;Tseng P.-H.;Chang L.;Chang W.-H.;Wang H.-P.;Shun C.-T.;Wu J.-Y.;Yi-Chia Lee;Lin J.-T.;Wu M.-S.;Lin C.-H.;Chow L.-P.;Cheng T.-Y.;Wu C.-Y.;Lee Ching-Tai C.-T, Wang W.-L.;Tai C.-M.;Wang Y.-C.;Wang C.-H.;Kuo S.-H.;Wu C.-Y.; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; YI-CHIA LEE; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:24:57Z |
Relationship between pancreatic cancer-associated diabetes and cachexia
|
Liao W.-C.; Chen P.-R.; Huang C.-C.; Chang Y.-T.; Huang B.-S.; Chang C.-C.; MING-SHIANG WU; Chow L.-P. |
| 臺大學術典藏 |
2021-02-02T02:22:17Z |
Subcellular and functional proteomic analysis of the cellular responses induced by Helicobacter pylori
|
Chan C.-H.; Ko C.-C.; Chang J.-G.; Chen S.-F.; MING-SHIANG WU; Lin J.-T.; Chow L.-P. |
| 臺大學術典藏 |
2021-02-02T02:22:15Z |
Comparative immunoproteomics of idenfication and characterization of virulence factors from helicobacter pylori related to gastric cancer
|
Lin Y.-F.; MING-SHIANG WU; Chang C.-C.; Lin S.-W.; Lin J.-T.; Sun Y.-J.; Chen D.-S.; Chow L.-P. |
| 臺大學術典藏 |
2021-02-02T02:22:06Z |
Duodenal ulcer-related antigens from Helicobacter pylori: Immunoproteome and protein microarray approaches
|
Lin Y.-F.; Chen C.-Y.; Tsai M.-H.; MING-SHIANG WU; Wang Y.-C.; Chuang E.Y.; Lin J.-T.; Yang P.-C.; Chow L.-P. |
| 臺大學術典藏 |
2021-02-02T02:22:03Z |
Proteomic identification of biomarkers related to Helicobacter pylori-associated gastroduodenal disease: Challenges and opportunities
|
MING-SHIANG WU; Chow L.-P.; Lin J.-T.; Chiou S.-H. |
| 臺大學術典藏 |
2021-02-02T02:21:36Z |
VCP Phosphorylation-Dependent Interaction Partners Prevent Apoptosis in Helicobacter pylori-Infected Gastric Epithelial Cells
|
Yu C.-C.; Yang J.-C.; Chang Y.-C.; Chuang J.-G.; Lin C.-W.; MING-SHIANG WU; Chow L.-P. |
| 臺大學術典藏 |
2021-02-02T02:21:35Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; MING-SHIANG WU; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:20:43Z |
Galectin-3 and S100A9: Novel diabetogenic factors mediating pancreatic cancer-associated diabetes
|
Liao W.-C.; Huang B.-S.; Yu Y.-H.; Yang H.-H.; Chen P.-R.; Huang C.-C.; Huang H.-Y.; MING-SHIANG WU; Chow L.-P. |
| 臺大學術典藏 |
2021-01-15T03:46:53Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; HSIU-PO WANG; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-01-06T08:23:30Z |
Inhibition of Rho-associated kinase relieves C5a-induced proteinuria in murine nephrotic syndrome
|
Tsai I.-J.; Chou C.-H.; YAO-HSU YANG; Lin W.-C.; Lin Y.-H.; Chow L.-P.; Lee H.-H.; Kao P.-G.; Liau W.-T.; Jou T.-S.; Tsau Y.-K. |
| 臺大學術典藏 |
2020-12-29T08:15:43Z |
Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma
|
Chung, Y.-H.; Hsu, S.-T.; Huang, J.-X.; Wu, J.-Y.; Lee, H.-H.; Chang, Y.-H.; Huang, C.-W.; Huang, C.-W.;Chang, Y.-H.;Lee, H.-H.;Wu, J.-Y.;Huang, J.-X.;Chung, Y.-H.;Hsu, S.-T.;Chow, L.-P.;Wei, K.-C.;Huang, F.-T.; Chow, L.-P.; Wei, K.-C.; Huang, F.-T.; FENG-TING HUANG |
| 臺大學術典藏 |
2020-12-21T08:19:29Z |
Inhibition of Rho-associated kinase relieves C5a-induced proteinuria in murine nephrotic syndrome
|
I-JUNG TSAI; Chou C.-H.; Yang Y.-H.; Lin W.-C.; Lin Y.-H.; Chow L.-P.; Lee H.-H.; Kao P.-G.; Liau W.-T.; Jou T.-S.; Tsau Y.-K. |
| 臺大學術典藏 |
2020-12-04T04:19:11Z |
Proteomic approach to study the effects of various oxidatively modified low-density lipoprotein on regulation of protein expression in human umbilical vein endothelial cell
|
Chen C.-Y.; CHII-MING LEE; Hsu H.-C.; Yang C.-Y.; Chow L.-P.; Lee Y.-T. |
| 臺大學術典藏 |
2020-12-02T02:34:42Z |
Duodenal ulcer-related antigens from Helicobacter pylori: Immunoproteome and protein microarray approaches
|
Lin Y.-F.;Chen C.-Y.;Tsai M.-H.;Wu M.-S.;Wang Y.-C.;Chuang E.Y.;Lin J.-T.;Pan-Chyr Yang;Chow L.-P.; Lin Y.-F.; Chen C.-Y.; Tsai M.-H.; Wu M.-S.; Wang Y.-C.; Chuang E.Y.; Lin J.-T.; PAN-CHYR YANG; Chow L.-P. |
| 臺大學術典藏 |
2020-12-02T02:33:58Z |
Development of an AlphaLISA assay to quantify serum core-fucosylated E-cadherin as a metastatic lung adenocarcinoma biomarker
|
Wen C.-L.; Chen K.-Y.; Chen C.-T.; Chuang J.-G.; Pan-Chyr Yang; Chow L.-P.; Wen C.-L.; Chen K.-Y.; Chen C.-T.; Chuang J.-G.; PAN-CHYR YANG; Chow L.-P. |
| 臺大學術典藏 |
2020-12-02T02:33:42Z |
The antitumor agent PBT-1 directly targets HSP90 and hnRNP A2/B1 and inhibits lung adenocarcinoma growth and metastasis
|
Chen C.-Y.;Yang S.-C.;Lee K.-H.;Yang X.;Wei L.-Y.;Chow L.-P.;Wang T.-C.V.;Hong T.-M.;Lin J.-C.;Kuan C.;PAN-CHYR YANG; Chen C.-Y.; Yang S.-C.; Lee K.-H.; Yang X.; Wei L.-Y.; Chow L.-P.; Wang T.-C.V.; Hong T.-M.; Lin J.-C.; Kuan C.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-11-27T03:28:40Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; CHIEH-CHANG CHEN; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chien-Chuan Chen; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-03T07:37:10Z |
Galectin-3 and S100A9: Novel diabetogenic factors mediating pancreatic cancer-associated diabetes
|
Chow L.-P.; Wu M.-S.; Huang H.-Y.; Huang C.-C.; Chen P.-R.; Yang H.-H.; Yu Y.-H.; Huang B.-S.; WEI-CHIH LIAO |
| 臺大學術典藏 |
2020-11-03T07:37:08Z |
Relationship between pancreatic cancer-associated diabetes and cachexia
|
WEI-CHIH LIAO; Chen P.-R.; Huang C.-C.; Chang Y.-T.; Huang B.-S.; Chang C.-C.; Wu M.-S.; Chow L.-P. |
| 臺大學術典藏 |
2020-11-02T02:05:09Z |
Duodenal ulcer-related antigens from Helicobacter pylori: Immunoproteome and protein microarray approaches
|
Lin Y.-F.; Chen C.-Y.; Tsai M.-H.; MING-SHIANG WU; Wang Y.-C.; Chuang E.Y.; Lin J.-T.; Yang P.-C.; Chow L.-P. |
| 臺大學術典藏 |
2020-11-02T02:05:06Z |
Proteomic identification of biomarkers related to Helicobacter pylori-associated gastroduodenal disease: Challenges and opportunities
|
Chiou S.-H.; Lin J.-T.; Chow L.-P.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:45Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; MING-SHIANG WU; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L. |
| 臺大學術典藏 |
2020-11-02T02:04:03Z |
Galectin-3 and S100A9: Novel diabetogenic factors mediating pancreatic cancer-associated diabetes
|
Liao W.-C.; Huang B.-S.; Yu Y.-H.; Yang H.-H.; Chen P.-R.; Huang C.-C.; Huang H.-Y.; MING-SHIANG WU; Chow L.-P. |
| 臺大學術典藏 |
2020-10-22T07:41:48Z |
Mechanisms controlling the effects of bevacizumab (Avastin) on the inhibition of early but not late formed corneal neovascularization
|
Hu F.-R.; Chen C.-T.; Chow L.-P.; Lin C.-T.; Chu H.-S.; Chen Y.-M.; WEI-LI CHEN |
